A routine part of the process for developing National Institute for Health and Care Excellence (NICE) medical technologies guidance is a submission of clinical and economic evidence by the technology manufacturer. The Birmingham and Brunel Consortium External Assessment Centre (EAC; a consortium of the University of Birmingham and Brunel University) independently appraised the submission on the EXOGEN bone healing system for long bone fractures with non-union or delayed healing. This article is an overview of the original evidence submitted, the EAC's findings, and the final NICE guidance issued.

Original publication

DOI

10.1007/s40258-014-0117-6

Type

Journal article

Journal

Appl Health Econ Health Policy

Publication Date

10/2014

Volume

12

Pages

477 - 484

Keywords

Adult, Advisory Committees, Aged, Aged, 80 and over, Cost-Benefit Analysis, Female, Femur, Fibula, Fracture Healing, Fractures, Ununited, Humans, Humerus, Male, Middle Aged, Radius, Technology Assessment, Biomedical, Tibia, Ulna, Ultrasonic Therapy, Ultrasonography, United Kingdom, Young Adult